Dr. Margaret (Meg) Haney is a Professor of Neurobiology (in Psychiatry) at the Columbia University Medical Center. As the Director of the Cannabis Research Laboratory and Co-Director of the Substance Use Research Center, Dr. Haney is internationally recognized for her expertise is in human laboratory studies of cannabis and cannabinoids. She and her colleagues were one of the first to empirically demonstrate a time-dependent, pharmacologically-specific cannabis withdrawal syndrome in humans. She has since developed an inpatient laboratory model of cannabis intoxication, withdrawal and relapse to test the efficacy of potential treatment medications for Cannabis Use Disorder.

An additional interest is in conducting placebo-controlled studies to test the potential therapeutic effects of cannabis and its constituents for a range of indications, including appetite-enhancement, experimental pain, chemotherapy-induced neuropathy, glioblastoma, Obsessive Compulsive Disorder, and Post-traumatic Stress Disorder.

Dr. Haney’s research has been continuously supported by the National Institute of Health since 1999. She has authored more than 135 articles in peer-reviewed journals, 11 book chapters, is an Associate Editor for Cannabis and Cannabinoid Research, is an Advisory Editor for Psychopharmacology, and recently co-edited Neuropsychopharmacology Reviews 2018, Cannabis and Cannabinoids: From Synapse to Society.

Dr. Haney is a longstanding participant in NIH review groups, is a Fellow at the American College of Neuropsychopharmacology, and the President-Elect of the College on Problems of Drug Dependence.